Rockwell Medical (NASDAQ:RMTI) Downgraded by StockNews.com to Hold

StockNews.com lowered shares of Rockwell Medical (NASDAQ:RMTI) from a buy rating to a hold rating in a report released on Friday morning.

A number of other research analysts have also recently issued reports on the company. RODMAN&RENSHAW raised Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. HC Wainwright cut their price objective on Rockwell Medical from $9.00 to $7.00 and set a “buy” rating on the stock in a report on Monday, November 25th. Finally, Rodman & Renshaw started coverage on Rockwell Medical in a research note on Thursday, November 14th. They set a “buy” rating and a $5.00 target price for the company.

Rockwell Medical Trading Up 1.5 %

Shares of NASDAQ RMTI opened at $2.08 on Friday. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. Rockwell Medical has a twelve month low of $1.16 and a twelve month high of $5.15. The company’s fifty day moving average is $2.89 and its 200-day moving average is $2.71. The stock has a market cap of $67.22 million, a price-to-earnings ratio of -41.60 and a beta of 1.38.

Institutional Trading of Rockwell Medical

A number of institutional investors have recently modified their holdings of the company. Renaissance Technologies LLC grew its stake in shares of Rockwell Medical by 877.1% during the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after acquiring an additional 92,189 shares in the last quarter. Armistice Capital LLC boosted its holdings in Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after purchasing an additional 592,000 shares during the last quarter. Beacon Financial Advisory LLC bought a new position in Rockwell Medical in the third quarter valued at $98,000. Concurrent Investment Advisors LLC bought a new position in Rockwell Medical in the third quarter valued at $40,000. Finally, Verus Capital Partners LLC acquired a new stake in Rockwell Medical in the 3rd quarter valued at $51,000. 23.31% of the stock is currently owned by institutional investors.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.